Please login to the form below

Not currently logged in
Email:
Password:

Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO

He takes over from the UK biotech company's co-founder Michael Walker

Verona Pharma has appointed Dr Sven Jan-Anders Karlsson to be the respiratory-focused biotech's new CEO.

He replaces Michael Walker, one of the UK-based company's co-founders, who is stepping down from his position but will remain as a senior scientific advisor to the board.

Dr Karlsson was most recently a director of S*BIO, a Singapore- and US-based biotech focused on developing small molecule anti-cancer drugs.

Prior to his time at S*BIO, Dr Karlsson was executive VP of pharma global research at Bayer Healthcare and before that he held senior leadership positions at Rhone-Poulenc Rorer (now Sanofi) and Astra (now AstraZeneca).

“We have taken time to identify and recruit the right person to take over from Michael after he had notified the Board of his intention to step down,” said company chair Professor Clive Page.

“We believe Jan-Anders' experience in the pharmaceutical and biotechnology sector will be invaluable to Verona Pharma as we move our clinical programmes forward, and continue to grow and expand the company. We very much look forward to working with him.”

2nd May 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics